Cephalon Preps For Provigil Label Expansion, Wins Bid For CIMA
Cephalon is enlarging its sales force to 500 reps in anticipation of FDA approval for an expanded wakefulness indication for Provigil, CEO Frank Baldino told analysts Nov. 3
Cephalon is enlarging its sales force to 500 reps in anticipation of FDA approval for an expanded wakefulness indication for Provigil, CEO Frank Baldino told analysts Nov. 3